Schedule J
(Form 990)
Department of the Treasury
Internal Revenue Service
Compensation Information
For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
medium right arrow graphic Complete if the organization answered "Yes" on Form 990, Part IV, line 23.
medium right arrow graphic Attach to Form 990.
medium right arrow graphic Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2022
Open to Public Inspection
Name of the organization
LEGACY MERIDIAN PARK HOSPITAL
 
Employer identification number

93-0618975
Part I
Questions Regarding Compensation
Yes
No
1a
Check the appropiate box(es) if the organization provided any of the following to or for a person listed on Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.
b
If any of the boxes on Line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain .....
1b
 
 
2
Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
directors, trustees, officers, including the CEO/Executive Director, regarding the items checked on Line 1a? ....
2
 
 
3
Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.
4
During the year, did any person listed on Form 990, Part VII, Section A, line 1a, with respect to the filing organization or a related organization:
a
Receive a severance payment or change-of-control payment? .............
4a
Yes
 
b
Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........
4b
Yes
 
c
Participate in, or receive payment from, an equity-based compensation arrangement? .........
4c
 
No
If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.
Only 501(c)(3), 501(c)(4), and 501(c)(29) organizations must complete lines 5-9.
5
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:
a
The organization? ....................
5a
Yes
 
b
Any related organization? .......................
5b
Yes
 
If "Yes," on line 5a or 5b, describe in Part III.
6
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:
a
The organization? ..................
6a
Yes
 
b
Any related organization? ......................
6b
Yes
 
If "Yes," on line 6a or 6b, describe in Part III.
7
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization provide any nonfixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............
7
 
No
8
Were any amounts reported on Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III ..........................
8
Yes
 
9
If "Yes" on line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................
9
Yes
 
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50053T
Schedule J (Form 990) 2022
Page 2

Schedule J (Form 990) 2022
Page 2
Part II
Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.
For each individual whose compensation must be reported on Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.
(A) Name and Title (B) Breakdown of W-2, 1099-MISC compensation, and/or 1099-NEC (C) Retirement and other deferred compensation (D) Nontaxable
benefits
(E) Total of columns
(B)(i)-(D)
(F) Compensation in column (B) reported as deferred on prior Form 990
(i) Base
compensation
(ii) Bonus & incentive
compensation
(iii) Other reportable compensation
1ALEXANDER GLADNEY
Secretary
(i)

(ii)
 
-------------
714,135
 
-------------
175,000
 
-------------
-2,850
 
-------------
8,862
 
-------------
32,232
 
-------------
927,379
 
-------------
 
2ANITA N IYENGER
SR VP
(i)

(ii)
 
-------------
681,904
 
-------------
 
 
-------------
-4,906
 
-------------
-17,629
 
-------------
26,331
 
-------------
685,700
 
-------------
 
3ANNA LOOMIS
CFO & TREASURER
(i)

(ii)
 
-------------
926,864
 
-------------
 
 
-------------
-3,743
 
-------------
15,250
 
-------------
27,575
 
-------------
965,946
 
-------------
 
4ANNE T GREER
FORMER INT VP & SECRETARY
(i)

(ii)
 
-------------
37,602
 
-------------
 
 
-------------
334,886
 
-------------
-6,422
 
-------------
2,056
 
-------------
368,122
 
-------------
 
5BRIAN M BEDOLLA MD
MEDICAL DIRECTOR
(i)

(ii)
248,812
-------------
 
24,311
-------------
 
5,156
-------------
 
22,843
-------------
 
36,378
-------------
 
337,500
-------------
 
 
-------------
 
6BRYCE R HELGERSON
FORMER SR. VP
(i)

(ii)
 
-------------
155,209
 
-------------
 
 
-------------
782,244
 
-------------
-82,689
 
-------------
3,797
 
-------------
858,561
 
-------------
 
7CHRISTOPHER THOMING MD
INTERIM PRESIDENT
(i)

(ii)
491,768
-------------
 
46,802
-------------
 
1,958
-------------
 
15,250
-------------
 
55,943
-------------
 
611,721
-------------
 
 
-------------
 
8ELIZABETH R SAMMOND MD
MEDICAL DIRECTOR
(i)

(ii)
244,053
-------------
 
72,959
-------------
 
-5,560
-------------
 
16,970
-------------
 
26,025
-------------
 
354,447
-------------
 
 
-------------
 
9ERIC J MACEVOY MD
MEDICAL DIRECTOR
(i)

(ii)
287,175
-------------
 
78,637
-------------
 
-9,549
-------------
 
-5,185
-------------
 
30,745
-------------
 
381,823
-------------
 
 
-------------
 
10GWEN J GREWE MD
FORMER VP
(i)

(ii)
102,118
-------------
289,981
15,318
-------------
 
-1,323
-------------
1,407
 
-------------
32,025
11,858
-------------
24,223
127,971
-------------
347,636
 
-------------
 
11JOHN J KENAGY
SR VP
(i)

(ii)
 
-------------
667,187
 
-------------
29,679
 
-------------
37,067
 
-------------
-21,931
 
-------------
41,379
 
-------------
753,381
 
-------------
 
12JONATHAN E AVERY
HOSPITAL PRESIDENT
(i)

(ii)
653,354
-------------
 
61,145
-------------
 
23,722
-------------
 
7,161
-------------
 
42,532
-------------
 
787,914
-------------
 
 
-------------
 
13JONATHAN HILL MD
BOARD DIRECTOR
(i)

(ii)
 
-------------
309,301
 
-------------
25,000
 
-------------
12,080
 
-------------
12,200
 
-------------
38,877
 
-------------
397,458
 
-------------
 
14KATHRYN CORREIA
President & CEO
(i)

(ii)
 
-------------
1,847,531
 
-------------
 
 
-------------
293,739
 
-------------
-617
 
-------------
44,970
 
-------------
2,185,623
 
-------------
 
15KECIA M KELLY DNP
SR VP
(i)

(ii)
 
-------------
488,702
 
-------------
51,101
 
-------------
-9,683
 
-------------
11,907
 
-------------
36,433
 
-------------
578,460
 
-------------
 
16LESLIE ROOT MD
BOARD DIRECTOR
(i)

(ii)
 
-------------
132,194
 
-------------
91,681
 
-------------
-4,058
 
-------------
-7,497
 
-------------
25,027
 
-------------
237,347
 
-------------
 
17LISA J GOREN
SR VP
(i)

(ii)
 
-------------
486,750
 
-------------
 
 
-------------
-3,345
 
-------------
28,506
 
-------------
25,191
 
-------------
537,102
 
-------------
 
18MAUREEN A BRADLEY
SR VP
(i)

(ii)
 
-------------
411,327
 
-------------
 
 
-------------
7,823
 
-------------
-24,803
 
-------------
19,458
 
-------------
413,805
 
-------------
 
19MELINDA C STIBAL RN
VP
(i)

(ii)
367,525
-------------
 
 
-------------
 
3,506
-------------
 
14,756
-------------
 
31,469
-------------
 
417,256
-------------
 
 
-------------
 
20MELINDA J MULLER MD
SR VP
(i)

(ii)
 
-------------
545,803
 
-------------
12,778
 
-------------
2,823
 
-------------
-28,952
 
-------------
40,384
 
-------------
572,836
 
-------------
 
21POMPY Z GOSWAMI MD
PHYSICIAN
(i)

(ii)
184,892
-------------
 
117,947
-------------
 
-4,062
-------------
 
-11,996
-------------
 
23,547
-------------
 
310,328
-------------
 
 
-------------
 
22SETH R PODOLSKY MD
SR VP
(i)

(ii)
 
-------------
644,050
 
-------------
30,000
 
-------------
686,221
 
-------------
-6,017
 
-------------
37,977
 
-------------
1,392,231
 
-------------
 
23SHEILA BANGERT RN
REGISTERED NURSE
(i)

(ii)
179,463
-------------
 
107,994
-------------
 
-238
-------------
 
10,252
-------------
 
11,157
-------------
 
308,628
-------------
 
 
-------------
 
24SONJA O STEVES
FORMER SR. VP
(i)

(ii)
 
-------------
85,581
 
-------------
402
 
-------------
57,937
 
-------------
-75,295
 
-------------
9,379
 
-------------
78,004
 
-------------
 
25TRENT S GREEN
SR VP
(i)

(ii)
 
-------------
574,423
 
-------------
 
 
-------------
241,698
 
-------------
-15,586
 
-------------
21,345
 
-------------
821,880
 
-------------
 
Schedule J (Form 990) 2022
Page 3

Schedule J (Form 990) 2022
Page 3
Part III
Supplemental Information
Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II. Also complete this part for any additional information.
Return Reference Explanation
Part I, Line 1a: Relevant information in regards to selections on 1a. Legacy does periodically reimburse for some travel of companions. During 2022, no travel expenses for companions of Legacy Board Directors and executives were reimbursed. These transactions follow Legacys reimbursement policy requiring documentation and approval of the expenses, prior to reimbursement. These payments are taxable to the individuals and are reported on a W-2 for employees or a 1099 forBoard Directors. A $2,000 taxable stipend is provided to the medical staff leadership,as guests do travel with medical staff members to conferences.
Part I, Line 5b: Explanation of organization compensation based on revenues of related organization Physicians employed by Legacy affiliates are paid variable compensation based on quality, value, and production. Production is based upon the level of effort of services provided during the year measured by industry standard relative value units (RVU) and which generate revenue.
Part I, Line 6b: Explanation of organization compensation contingent on net earnings from related or Legacy has an at-risk incentive compensation plan for management. The plan is based on meeting goals related to employee engagement, work processes, customer service, clinical quality, financial management, and certain key strategic tactics. In order to payout any at-risk incentive compensation, Legacy must exceed operating margin targets.
Part I, Line 8: Amounts reported on 990 VII pursuant to initial contract exemption described in Regs Legacy enters into initial employment agreements with Executives that qualify under the initial contract exception. The Compensation Committee of the Board of Directors, none of whom is a Legacy employee, reviews the compensation for key executive positions. The Committee relies on comparable market data and all decisions are documented.
Part III, Additional Information Sch J, Part 1, Question 3 Regarding Compensation PracticesDirectors for Legacy started receiving compensation for their services in August 2014. They also receive expense reimbursements related to their duties. Any expense reimbursements to board members are reviewed by the Director of Tax for determining 1099 tax reporting. In addition to the Board of Directors compensation, during 2022, Dr. Hill received compensation related to his duties as Clinical VP while Dr. Root received compensation for medical services provided at Legacy Emanuel Hospital. There was no other reportable compensation received by any board member during 2022.Executive compensation for Legacy is designed to recruit, retain and motivate qualified senior management personnel. The comprehensive compensation plan is designed for positions that have a significant impact on the high-level strategic and policy direction of Legacy and its affiliates. Base pay and total compensation (including incentive compensation) for similar positions is established at a level comparable to market compensation for healthcare organizations. External consultants are regularly used to review published compensation surveys of comparable organizations and comparable benchmark positions in the market. The Compensation Committee of the Board of Directors, none of whom is a Legacy employee, reviews the compensation for executive positions. The Committee oversees the system's governance procedures with respect to intermediate sanctions legislation and the evaluation of reasonableness of compensation. The Committee reports to the Board in sufficient detail to enable the entire Board to take such actions as are required to obtain the rebuttable presumption of reasonableness. The Compensation Committee also reviews tax-reporting disclosures.Sch J, Part II, Column Breakdown of W-2 or Misc-1099:Column B(i) - Base compensation consists of regular base pay including employee elected deferrals for retirement plans (403(b) and 457(b) plans).Column B(ii) - The incentive compensation program for Legacy is based on predetermined criteria and reviewed and approved by the Board. Bonuses are paid to key employees for interim duties outside their primary responsibilities (e.g. Acting in Capacity).Column B(iii) - Other compensation consists of deferred compensation amounts paid to executives during the current year and were reported on prior form 990 returns. These amounts include arrangements that contain elements of a substantial risk of forfeiture conditioned on continued employment, vesting and/or a noncompete provision upon termination of employment. Distributions from 457(b) plans, reported to the employee on a 1099-R, are also included as other compensation. In addition, imputed income for insurance and other benefits is included in other compensation as well as any severance related payments. Sch J, Part II, Column Breakdown of W-2 or Misc-1099 (Cont):Column C - Deferred compensation includes the contributions to defined contribution plans, amounts deferred under the 457(f) plan including earnings, earnings in the 457(b) plan, and the value of the pension restoration plan. Earnings on the 457(f) and 457(b) include gains and losses on the underlying investments. The defined contribution plan is available to all employees as they become qualified to participate. The pension restoration plan provides executive pension benefits in excess of IRS mandated limits on eligible compensation to key executives. The benefits are unfunded and subject to forfeiture. Executive pension benefits are intended to make the executive's retirement benefit, as a proportion of their final average salary, comparable to all other employees, and are treated as income when paid.Column D - Nontaxable benefits include company paid health and welfare and long-term care and disability benefits under group plans.Column F - Current year compensation reported as deferred in prior years.
Schedule J (Form 990) 2022

Additional Data


Software ID: 22015553
Software Version: 2022v5.0